Physician profile
Kevin Triggs
NPI 1699762500
$2,342.84
in general payments reported to CMS, 2019-2025
24 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $746 · 2021: $320 · 2022: $436 · 2023: $162 · 2024: $84.79 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $607.57 | 2019-2021 | |
| Smith+Nephew, INC. | $295.51 | 2020-2025 | Lens 4k, Bioinductive Implant With Arthroscopic Delivery System - Medium, Acufex |
| Horizon Therapeutics Plc | $255.04 | 2019-2023 | Krystexxa |
| Depuy Synthes Sales INC. | $180.33 | 2019-2022 | |
| Ethicon US, LLC | $161.33 | 2020-2023 | Dermabond Prineo |
| Zimmer Biomet Holdings, INC. | $105.72 | 2019-2024 | Gel-One Cross-Linked Hyaluronate |
| Fidia Pharma USA INC. | $105.14 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $103.34 | 2019-2022 | |
| Davol INC. | $88.10 | 2020-2024 | Arista Ah Flexitip |
| Stryker Corporation | $64.74 | 2025 | Mako |
| Baxter Healthcare | $59.44 | 2025 | Floseal |
| Pacira Pharmaceuticals Incorporated | $54.61 | 2020-2023 | Zilretta, Iovera, Exparel |
| Heron Therapeutics, INC. | $41.99 | 2021-2022 | |
| Innovation Technologies INC | $23.34 | 2024 | Irrisept |
| Curonix LLC | $22.57 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $22.08 | 2022 | |
| Novo Nordisk INC | $21.40 | 2020 | |
| Abbott Laboratories | $21.04 | 2025 | Eterna |
| Avanos Medical | $20.68 | 2019 | |
| Baudax Bio INC. | $19.43 | 2021 | |
| Radius Health, INC. | $19.39 | 2021 | |
| Pfizer INC. | $17.66 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $16.94 | 2022 | |
| Si-Bone, INC. | $15.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Triggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.